PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TEVA vs. INCR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TEVA and INCR is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

TEVA vs. INCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teva Pharmaceutical Industries Limited (TEVA) and INC Research Holdings Inc (INCR). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
0.89%
-17.83%
TEVA
INCR

Key characteristics

Sharpe Ratio

TEVA:

0.84

INCR:

0.43

Sortino Ratio

TEVA:

1.72

INCR:

1.28

Omega Ratio

TEVA:

1.22

INCR:

1.15

Calmar Ratio

TEVA:

0.45

INCR:

0.37

Martin Ratio

TEVA:

5.97

INCR:

0.84

Ulcer Index

TEVA:

6.18%

INCR:

40.59%

Daily Std Dev

TEVA:

44.15%

INCR:

80.18%

Max Drawdown

TEVA:

-90.80%

INCR:

-94.32%

Current Drawdown

TEVA:

-74.53%

INCR:

-90.95%

Fundamentals

Market Cap

TEVA:

$19.33B

INCR:

$73.68M

EPS

TEVA:

-$1.43

INCR:

-$0.40

Total Revenue (TTM)

TEVA:

$16.56B

INCR:

$125.73M

Gross Profit (TTM)

TEVA:

$8.07B

INCR:

$41.66M

EBITDA (TTM)

TEVA:

$480.00M

INCR:

$14.40M

Returns By Period

In the year-to-date period, TEVA achieves a -22.60% return, which is significantly lower than INCR's 1.26% return.


TEVA

YTD

-22.60%

1M

-19.68%

6M

0.89%

1Y

37.80%

5Y*

7.11%

10Y*

-10.74%

INCR

YTD

1.26%

1M

-2.79%

6M

-17.86%

1Y

27.78%

5Y*

-20.15%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TEVA vs. INCR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TEVA
The Risk-Adjusted Performance Rank of TEVA is 7575
Overall Rank
The Sharpe Ratio Rank of TEVA is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of TEVA is 7676
Sortino Ratio Rank
The Omega Ratio Rank of TEVA is 7474
Omega Ratio Rank
The Calmar Ratio Rank of TEVA is 6666
Calmar Ratio Rank
The Martin Ratio Rank of TEVA is 8484
Martin Ratio Rank

INCR
The Risk-Adjusted Performance Rank of INCR is 6262
Overall Rank
The Sharpe Ratio Rank of INCR is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of INCR is 6666
Sortino Ratio Rank
The Omega Ratio Rank of INCR is 6262
Omega Ratio Rank
The Calmar Ratio Rank of INCR is 6464
Calmar Ratio Rank
The Martin Ratio Rank of INCR is 5757
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TEVA vs. INCR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and INC Research Holdings Inc (INCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TEVA, currently valued at 0.84, compared to the broader market-2.000.002.004.000.840.43
The chart of Sortino ratio for TEVA, currently valued at 1.72, compared to the broader market-4.00-2.000.002.004.001.721.28
The chart of Omega ratio for TEVA, currently valued at 1.22, compared to the broader market0.501.001.502.001.221.15
The chart of Calmar ratio for TEVA, currently valued at 0.92, compared to the broader market0.002.004.006.000.920.37
The chart of Martin ratio for TEVA, currently valued at 5.97, compared to the broader market-10.000.0010.0020.005.970.84
TEVA
INCR

The current TEVA Sharpe Ratio is 0.84, which is higher than the INCR Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of TEVA and INCR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.84
0.43
TEVA
INCR

Dividends

TEVA vs. INCR - Dividend Comparison

Neither TEVA nor INCR has paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.49%3.75%2.07%2.38%
INCR
INC Research Holdings Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

TEVA vs. INCR - Drawdown Comparison

The maximum TEVA drawdown since its inception was -90.80%, roughly equal to the maximum INCR drawdown of -94.32%. Use the drawdown chart below to compare losses from any high point for TEVA and INCR. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-25.08%
-90.95%
TEVA
INCR

Volatility

TEVA vs. INCR - Volatility Comparison

Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 17.02% compared to INC Research Holdings Inc (INCR) at 9.79%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than INCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
17.02%
9.79%
TEVA
INCR

Financials

TEVA vs. INCR - Financials Comparison

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and INC Research Holdings Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab